DawlingSEssexEGWardNWiddopB. Rapid measurement of basic drugs in blood applied to clinical and forensic toxicology. Ann Clin Biochem (in press).
2.
LinnoilaMDorrityF. Measurement of plasma and erythrocyte chlorpromazine and N-monodesmethylchlorpromazine levels by gas chromatography with a nitrogen sensitive detector. Acta Pharm Toxicol1978; 42: 264–70.
3.
JonesGRPounderDJ. Site dependence of drug concentrations in postmortem blood—a case study. J Anal Toxicol1987; 11: 186–90.
4.
LogaSCurrySLaderM. Interactions of orphenadrine and phenobarbitone with chlorpromazine: Plasma concentrations and effects in man. Br J Clin Pharmacol1975; 2: 197–208.
5.
DahlSG. Active metabolites of neuroleptic drugs: Possible contribution to therapeutic and toxic effects. Ther Drug Monit1982; 4: 33–40.
6.
LogaSCurrySLaderM. Interaction of chlorpromazine and nortriptyline in patients with schizophrenia. Clin Pharmacokinet1981; 6: 454–62.
7.
MellströmBBertilssonLSäweJSchulzH-USjöqvistF. E- and Z-10-hydroxylation of nortriptyline: Relationship to polymorphic debrisoquin hydroxylation. Clin Pharmacol Ther1981; 30: 189–93.
8.
SteinerEBertilssonLSäweJBertlingISjöqvistF. Polymorphic debrisoquin hydroxylation in 757 Swedish subjects. Clin Pharmacol Ther1988; 44: 431–5.
9.
ScaddingGKAyeshRBrostoffJMitchellSCWaringRHSmithRL. Poor sulphoxidation ability in patients with food sensitivity. Br Med J1988; 297: 105–7.
10.
PhillipsonOTMcKeownJMBakerJHealeyAF. Correlation between plasma chlorpromazine and its metabolites and clinical ratings in patients with acute relapse of schizophrenic and paranoid psychosis. Br J Psychiatry1977; 131: 172–84.
11.
HenryJACassidySL. Membrane stabilizing activity: A major cause of fatal poisoning. Lancet1986; 1: 1414–7.
12.
SeemanPWeinsteinJ. Erythrocyte membrane stabilization by tranquilizers and antihistamines. Biochem Pharmacol1966; 15: 1737–52.
